Posted in | News | Lithium | Mining Business

Medaro Expands Soil Grid and Conducts Prospecting on Rapide Lithium Property

Medaro Mining Corp. ("Medaro" or the "Company") is delighted to announce successful completion of the 2023 exploration fieldwork program (the "Program") on the Rapide Lithium Property (the "Property") located in Val-d'Or, Quebec, Canada.

The focal point of the 2023 work program was to build upon the discoveries made in the previous year's soil anomalies by expanding the soil grid northward and establishing two additional soil grids in both the northern and southern sectors of the Property. This well-planned strategy is geared towards achieving comprehensive coverage and unlocking deeper insights for our exploration endeavors. Our dedicated team meticulously collected a total of 822 soil samples, which were then dispatched to Activation Laboratories (ACTLABS) in Ancaster, Ontario for thorough sample preparation and analysis.

Beyond the expansion of the soil grid, our fieldwork encompassed a range of activities such as prospecting, mapping, and rock chip sampling. The primary aim of these efforts was to thoroughly investigate the potential pegmatites that were found exposed during the soil sampling. Through our diligent work, we collected a total of 34 rock chip samples, each contributing to our growing knowledge base.

Medaro is also pleased to announce that it will mobilize a crew back to the Darlin project in the next 10 days. This will expand on the work completed the exploration work at the Darlin property announced June 6th. Over 240 samples were collected and are currently at the laboratory awaiting analysis. Results will be announced when received.

Michael Mulberry, CEO of Medaro, expressed his enthusiasm stating, "The completion of the 2023 exploration at Rapide program marks a significant milestone for Medaro Mining. Our systematic approach to expanding the soil grid and investigating potential pegmatites underscores our commitment to unlocking the full potential of the Rapide Lithium Property. The dedication of our field crew has been integral to the success of this phase. We look forward to the insights that the analytical results will provide as we move towards shaping the future of lithium exploration in Quebec."

Medaro Mining Corp. remains dedicated to advancing the exploration and development of the Rapide Lithium Property, with an unwavering commitment to responsible and sustainable mining practices.

The soil samples were taken at predetermined station IDs using a Garmin GPS to obtain ~ 3-meter accuracy where approximately 500 grams of material were selected when a B- soil horizon was present. All the samples were bagged and tagged using best practices and were delivered to Activation Laboratories ("ACTLABS"), Ancaster, Ontario for sample preparation and analyses using laboratories code Ultratrace 7 and sodium peroxide fusion (Na2O2). ACTLABS is an independent commercial, accredited ISO Certified Laboratory.

Medaro Mining Corp. will provide regular updates on the progress of the exploration fieldwork program as significant milestones are achieved. Stakeholders and interested parties are encouraged to follow the Company's news releases and website for the latest information.


Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Azthena logo powered by Azthena AI

Your AI Assistant finding answers from trusted AZoM content

Your AI Powered Scientific Assistant

Hi, I'm Azthena, you can trust me to find commercial scientific answers from

A few things you need to know before we start. Please read and accept to continue.

  • Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
  • Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
  • Large Language Models can make mistakes. Consider checking important information.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.